Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramzi F Sweis

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
ACS Medicinal Chemistry Letters|November 16, 2018
Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective AntagonistsWeiguo Liu, Zahid Hussain, Yi Zang, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacyRamzi F Sweis, Julianne A Hunt, Florida Kallashi, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Nature Chemical Biology|January 31, 2017
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ACS Medicinal Chemistry Letters|November 16, 2018
Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective AntagonistsWeiguo Liu, Zahid Hussain, Yi Zang, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacyRamzi F Sweis, Julianne A Hunt, Florida Kallashi, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Nature Chemical Biology|January 31, 2017
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complexYupeng He, Sujatha Selvaraju, Michael L Curtin, et al.
Pageof 2